cysteinyldopa - CISMeF

Preferred Label : cysteinyldopa;

MeSH definition : Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells.;

MeSH synonym : 5-s-cysteinyldopa; 5 s cysteinyldopa;

MeSH CAS label : L-Tyrosine, 3-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (R)-;

Registry Number MeSH : 19641-92-0;

MeSH annotation : /biosyn /physiol permitted;

Wikipedia link : https://en.wikipedia.org/wiki/Cysteinyldopa;

Is substance : O;

Details

Origin ID

D003548;

UMLS CUI

C0010665;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- 5-S-cysteinyldopa [LOINC component]
Record concept(s)
- cysteinyldopa [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2,5-S,S-dicysteinyldopa [MeSH Supplementary Concept]
- 2-S-cysteinyldopa [MeSH Supplementary Concept]
- 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid [MeSH Supplementary Concept]
- 5-S-cysteinyl-glycyl-dopa [MeSH Supplementary Concept]
- 5-S-glutathionyl-alpha-methyldopa [MeSH Supplementary Concept]
- 5-S-glutathionyldopamine [MeSH Supplementary Concept]
- 6-S-cysteinyldopa [MeSH Supplementary Concept]
- cysteinyldopa-melanin [MeSH Supplementary Concept]
- glutathionyldopa [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 5-S-cysteinyldopa [LOINC component]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients